IQVIA HOLDINGS INC. Deferred Federal, State and Local, Tax Expense (Benefit)
IQVIA HOLDINGS INC. (IQV) reported Deferred Federal, State and Local, Tax Expense (Benefit) of -$132.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit · last filed 2026-02-17
- IQVIA HOLDINGS INC. deferred federal, state and local, tax expense (benefit) for fiscal 2025 was -$132.00M.
- IQVIA HOLDINGS INC. deferred federal, state and local, tax expense (benefit) for fiscal 2024 was -$116.00M.
- IQVIA HOLDINGS INC. deferred federal, state and local, tax expense (benefit) for fiscal 2023 was -$236.00M.
- IQVIA HOLDINGS INC. deferred federal, state and local, tax expense (benefit) for fiscal 2022 was -$94.00M.
| Period end | Deferred Federal, State and Local, Tax Expense (Benefit) 12 month | Deferred Federal, State and Local, Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$132.00M 10-K · filed 2026-02-17 | |
| 2024-12-31 | -$116.00M 10-K · filed 2026-02-17 | |
| 2023-12-31 | -$236.00M 10-K · filed 2026-02-17 | |
| 2022-12-31 | -$94.00M 10-K · filed 2025-02-13 | |
| 2021-12-31 | -$106.00M 10-K · filed 2024-02-15 | |
| 2020-12-31 | -$161.00M 10-K · filed 2023-02-15 | |
| 2019-12-31 | -$109.00M 10-K · filed 2022-02-16 | |
| 2018-12-31 | -$170.00M 10-K · filed 2021-02-12 | |
| 2017-12-31 | -$1.17B 10-K · filed 2020-02-18 | -$1.17B 10-K · filed 2018-02-16 |
| 2016-12-31 | $151.00M 10-K · filed 2019-02-19 | $166.00M 10-K · filed 2017-02-16 |
| 2015-12-31 | $5.00M 10-K · filed 2018-02-16 | $4.61M 10-K · filed 2016-02-11 |
| 2014-12-31 | -$5.00M 10-K · filed 2017-02-16 | -$4.55M 10-K · filed 2016-02-11 |
| 2013-12-31 | -$15.81M 10-K · filed 2016-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |